Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K090002
    Date Cleared
    2009-08-07

    (217 days)

    Product Code
    Regulation Number
    876.5820
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Acid Concentrate is indicated for use as acid concentrate in hemodialysis therapy.

    Device Description

    Baxter's Acid Concentrate is used in the preparation of hemodialysis solutions when mixed and proportioned with the appropriate volumes of purified water and bicarbonate concentrate solution. These acid concentrate products are mixed and proportioned in a three-stream hemodialysis machine, in which the acid concentrate is proportioned into one stream, a bicarbonate concentrate solution is proportioned into the second stream, and purified water that meets AAMI Standards is proportioned into the third stream. These three streams are then mixed to prepare a final proportioned hemodialysis solution. The proportioned hemodialysis solution is then heated to body temperature and passed through the dialysis fluid compartment of a hemodialyzer counter-current to the flow of the patient's blood.

    AI/ML Overview

    The provided text describes a 510(k) premarket notification for Baxter's Acid Concentrate, a medical device. The information primarily focuses on establishing substantial equivalence to predicate devices rather than providing detailed performance metrics from a formal study for new device acceptance criteria against specific numerical targets.

    Here's an analysis based on the provided text, addressing your questions:

    1. Table of Acceptance Criteria and Reported Device Performance:

    Based on the document, specific numerical acceptance criteria and their corresponding reported device performance values are not explicitly stated in a quantifiable table format. The assessment is qualitative, focusing on equivalence.

    Acceptance CriterionReported Device Performance
    Safety"as safe as the predicate devices"
    Effectiveness"as effective as the predicate devices"
    Appropriate Design for Intended Use"devices are appropriately designed for their intended use."
    Compliance with Regulatory Standards"verified against established standards and guidelines for its intended use."
    Chemical Composition"utilizes... the same chemicals and compositions as the predicate devices."

    2. Sample size used for the test set and the data provenance:

    • Sample Size for Test Set: Not applicable/Not provided. The document does not describe a test set with individual samples for statistical analysis of performance. Instead, it refers to a "risk assessment" and "design verification tests" which are internal to the manufacturer.
    • Data Provenance: The "assessment of nonclinical data" and "design verification tests" are conducted by Baxter Healthcare Corporation (the manufacturer). This implies internal testing during the device's development and validation. The document does not specify country of origin for any external data, nor if the data was retrospective or prospective.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Not applicable/Not provided. The document does not describe a process of establishing ground truth using external experts for a test set in the way one might for an AI/diagnostic device. The "ground truth" here is the established safety and effectiveness of the predicate devices and compliance with regulatory standards, which is then demonstrated by Baxter's device.

    4. Adjudication method for the test set:

    • Not applicable/Not provided. There is no mention of an adjudication method, as there isn't a described test set requiring expert adjudication for ground truth.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • No. This type of study (MRMC, AI assistance) is not relevant to this device. Baxter's Acid Concentrate is a chemical solution used in hemodialysis, not an imaging or diagnostic device that would involve human readers or AI assistance in interpretation.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

    • No. This concept is not applicable to this device. There is no algorithm or AI component in Baxter's Acid Concentrate.

    7. The type of ground truth used:

    • The "ground truth" in this context is the established safety, effectiveness, and chemical composition of the legally marketed predicate devices, as well as relevant established standards and guidelines (e.g., ISO 14971:2003, AAMI Standards). The new device is compared to these established truths to demonstrate substantial equivalence.

    8. The sample size for the training set:

    • Not applicable/Not provided. There is no mention of a "training set" as this is not an AI/machine learning device. The "training" here would be the development and testing performed by the manufacturer to ensure the product meets its specifications and regulatory requirements.

    9. How the ground truth for the training set was established:

    • Not applicable/Not provided. Since there's no training set in the AI/ML sense, there's no ground truth established in that manner. The "ground truth" for the overall development and validation revolves around adherence to established chemical formulations, manufacturing processes, and successful performance in internal design verification tests against industry standards and predicate device characteristics.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1